Pfizer: Seriously Undervalued At Peak Pessimism (NYSE:PFE)


Share post:


Since my last article, Pfizer’s share price (NYSE:NYSE:PFE) has risen by over 10%, and I believe the bull run will continue.

This article will focus on several reasons why Pfizer is becoming an increasingly attractive asset among Big


Please enter your comment!
Please enter your name here

This is a test page

Related articles

Absent Since FTX 2022 Downfall, Sam Trabucco Breaks Silence With Letter Of Endorsement

In a recent development, Sam Trabucco, a key figure in Sam Bankman Fried's inner circle, has resurfaced...

This former Tesla engineer designed a battery that could make a $25K EV possible

Lithium-ion battery prices have dropped nearly 90% since 2008, the year that Tesla released its first electric...

‘We’ve actually found that people find these ads really helpful’: Google claims cramming ads into AI-generated search will help, not hurt users

Advertisers will get a front-row seat to Google’s generative AI search features. AI Overviews will have ads above,...